GSK3B and Alzheimer disease: It is reportedthat a MTDL with higher possibility of success “shouldbe directed to networked targets whose connectivity has been proven”,2 and GSK-3β fully satisfiesthis requirement representing a protein with plenty of tight connectionswith pathways and targets involved in AD pathogenesis.